TD Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-38,692
| Closed | -$1.23M | – | 1218 |
|
2024
Q4 | $1.23M | Sell |
38,692
-199,520
| -84% | -$6.37M | ﹤0.01% | 1088 |
|
2024
Q3 | $7.02M | Sell |
238,212
-73,620
| -24% | -$2.17M | 0.01% | 713 |
|
2024
Q2 | $12M | Sell |
311,832
-147,570
| -32% | -$5.66M | 0.01% | 592 |
|
2024
Q1 | $27M | Sell |
459,402
-23,920
| -5% | -$1.41M | 0.03% | 418 |
|
2023
Q4 | $28.9M | Buy |
483,322
+112,465
| +30% | +$6.73M | 0.03% | 388 |
|
2023
Q3 | $14.1M | Sell |
370,857
-107,869
| -23% | -$4.1M | 0.02% | 508 |
|
2023
Q2 | $43.6M | Buy |
478,726
+100,758
| +27% | +$9.18M | 0.05% | 293 |
|
2023
Q1 | $24.9M | Buy |
377,968
+106,348
| +39% | +$7.01M | 0.03% | 402 |
|
2022
Q4 | $14M | Sell |
271,620
-7,096
| -3% | -$367K | 0.02% | 518 |
|
2022
Q3 | $18.2M | Buy |
278,716
+4
| +0% | +$262 | 0.02% | 431 |
|
2022
Q2 | $12.6M | Buy |
278,712
+31,026
| +13% | +$1.4M | 0.01% | 546 |
|
2022
Q1 | $12.6M | Buy |
247,686
+86,641
| +54% | +$4.4M | 0.01% | 597 |
|
2021
Q4 | $7.61M | Buy |
161,045
+41,381
| +35% | +$1.96M | 0.01% | 748 |
|
2021
Q3 | $3.94M | Sell |
119,664
-19,738
| -14% | -$651K | ﹤0.01% | 886 |
|
2021
Q2 | $8.92M | Buy |
139,402
+36,779
| +36% | +$2.35M | 0.01% | 681 |
|
2021
Q1 | $4.4M | Buy |
102,623
+26,180
| +34% | +$1.12M | ﹤0.01% | 864 |
|
2020
Q4 | $4.37M | Buy |
76,443
+9,700
| +15% | +$555K | 0.01% | 827 |
|
2020
Q3 | $2.01M | Hold |
66,743
| – | – | ﹤0.01% | 905 |
|
2020
Q2 | $2.18M | Buy |
66,743
+35,500
| +114% | +$1.16M | ﹤0.01% | 858 |
|
2020
Q1 | $837K | Buy |
31,243
+8,478
| +37% | +$227K | ﹤0.01% | 1045 |
|
2019
Q4 | $697K | Hold |
22,765
| – | – | ﹤0.01% | 1184 |
|
2019
Q3 | $548K | Buy |
22,765
+5,824
| +34% | +$140K | ﹤0.01% | 1159 |
|
2019
Q2 | $429K | Hold |
16,941
| – | – | ﹤0.01% | 1207 |
|
2019
Q1 | $330K | Sell |
16,941
-2,900
| -15% | -$56.5K | ﹤0.01% | 1247 |
|
2018
Q4 | $262K | Buy |
19,841
+400
| +2% | +$5.28K | ﹤0.01% | 1323 |
|
2018
Q3 | $346K | Hold |
19,441
| – | – | ﹤0.01% | 1353 |
|
2018
Q2 | $428K | Buy |
+19,441
| New | +$428K | ﹤0.01% | 1292 |
|